Georg Ulrich Weigl

Title: Georg Ulrich Weigl: Innovator in Pharmaceutical Chemistry

Introduction

Georg Ulrich Weigl is a notable inventor based in Schaffhausen, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug synthesis. His work has implications for the production of important medicinal compounds.

Latest Patents

Weigl holds a patent for an "O-demethylating process of methoxy substituted morphinan-6-one derivatives." This invention relates to an improved method for O-demethylating these derivatives using AlCl3 as a demethylating agent in a reaction-inert solvent with a specific water content ranging from 0.1% wt to 0.8% wt. This process enhances the efficiency and effectiveness of synthesizing valuable pharmaceutical compounds.

Career Highlights

Georg Ulrich Weigl is associated with Noramco GmbH, a company known for its expertise in the production of active pharmaceutical ingredients. His role at Noramco has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in drug manufacturing.

Collaborations

Weigl has collaborated with several professionals in his field, including Dominik Stefan Stämpfli and Nelli Maurer. These collaborations have fostered a productive environment for research and development, leading to significant advancements in pharmaceutical processes.

Conclusion

Georg Ulrich Weigl is a prominent figure in pharmaceutical innovation, with a focus on improving drug synthesis processes. His contributions, particularly through his patent, demonstrate his commitment to advancing the field of pharmaceutical chemistry.